Healthcare Claims AI Fraud

Images, referral letters, prescriptions and supporting documents can be altered or fabricated to obtain drugs, treatments or reimbursements that may not be clinically appropriate or legitimately authorised. This risk is not theoretical. Healthcare payers and regulators are increasingly aware of attempts to exploit digital processes using falsified or synthetic evidence.

Recent global demand for weight loss and metabolic drugs has highlighted this exposure. Claims and access requests may be supported by images or documents that appear clinically valid but do not reflect genuine medical need or authorisation. When such evidence bypasses checks, the consequences extend beyond financial loss. Inappropriate access to prescription medication can create direct patient safety risks and place additional strain on already stretched healthcare systems.

Healthcare claims fraud also affects insurers and public health bodies through inflated costs, disputed reimbursements and delayed legitimate claims. When claims handlers or clinical reviewers must rely on digital submissions alone, the ability to trust the authenticity of supporting evidence becomes critical. Manual review is often insufficient to identify subtle manipulation or AI generated content, particularly at scale.

Humanly’s Healthcare Claims Fraud service is designed to support organisations that assess digital healthcare evidence as part of claims, authorisation or review processes. The service analyses images and documents to identify indicators of editing, manipulation or AI generation, providing an additional layer of assurance before decisions are made.

This capability is relevant across a range of healthcare workflows. In private and public health insurance, it supports the review of claim submissions for consultations, procedures and treatments. In pharmaceutical and prescription related processes, it helps assess the authenticity of documentation used to justify access to controlled or high demand medication. For healthcare providers and administrators, it can assist with internal reviews, audits and investigations where evidence integrity is in question.

Importantly, Humanly is not a clinical decision system and does not assess medical suitability or diagnosis. It focuses on the integrity of the digital evidence itself. By helping organisations understand whether submitted content appears genuine, altered or synthetic, Humanly supports safer and more reliable decision making alongside existing clinical, regulatory and fraud controls.

As healthcare systems continue to digitise and AI generated content becomes more accessible, the risk of evidence based fraud will grow. Organisations that rely on digital submissions will need to strengthen how authenticity is assessed, not only to reduce financial loss, but to protect patient safety and maintain trust in healthcare decision making. Humanly supports that objective by helping verify what is real before it is relied upon.